Abstract:The current crises in opioid abuse and chronic pain call for the development of nonopioid and nonpharmacological therapeutics for pain relief. Neuromodulation-based approaches, such as spinal cord stimulation, dorsal root ganglion simulation, and nerve stimulation including vagus nerve stimulation, have shown efficacy in achieving pain control in preclinical and clinical studies. However, the mechanisms by which neuromodulation alleviates pain are not fully understood. Accumulating evidence suggests that neuromodulation regulates inflammation and neuroinflammation—a localized inflammation in peripheral nerves, dorsal root ganglia/trigeminal ganglia, and spinal cord/brain—through neuro-immune interactions. Specialized proresolving mediators (SPMs) such as resolvins, protectins, maresins, and lipoxins are lipid molecules produced during the resolution phase of inflammation and exhibit multiple beneficial effects in resolving inflammation in various animal models. Recent studies suggest that SPMs inhibit inflammatory pain, postoperative pain, neuropathic pain, and cancer pain in rodent models via immune, glial, and neuronal modulations. It is noteworthy that sham surgery is sufficient to elevate resolvin levels and may serve as a model of resolution. Interestingly, it has been shown that the vagus nerve produces SPMs and vagus nerve stimulation (VNS) induces SPM production <i>in vitro</i>. In this review, we discuss how neuromodulation such as VNS controls pain via immunomodulation and neuro-immune interactions and highlight possible involvement of SPMs. In particular, we demonstrate that VNS via auricular electroacupuncture effectively attenuates chemotherapy-induced neuropathic pain. Furthermore, auricular stimulation is able to increase resolvin levels in mice. Thus, we propose that neuromodulation may control pain and inflammation/neuroinflammatioin via SPMs. Finally, we discuss key questions that remain unanswered in our understanding of how neuromodulation-based therapies provide short-term and long-term pain relief.

A Novel Neuromodulation Strategy to Enhance the Prefrontal Control to Treat Pain.

Enhancing Excitatory Activity of Somatosensory Cortex Alleviates Neuropathic Pain Through Regulating Homeostatic Plasticity

Role of Neuromodulation and Optogenetic Manipulation in Pain Treatment

The neural modulation effect of prefrontal cortex and related mechanism in non-pharmacological therapy of chronic pain

Frequency Dependent Electrical Stimulation of PFC and ACC for Acute Pain Treatment in Rats

Targeting Long‐term Depression of Excitatory Synaptic Transmission for the Treatment of Neuropathic Pain

Inhibition of the Prefrontal Projection to the Nucleus Accumbens Enhances Pain Sensitivity and Affect

The cellular mechanism by which the rostral ventromedial medulla acts on the spinal cord during chronic pain

Neuromodulation for Neuropathic Pain Syndromes

Low-intensity transcranial focused ultrasound suppresses pain by modulating pain processing brain circuits

Cortico-spinal Mechanisms of Periphery Neuromodulation induced Analgesia

Neuromodulation, Specialized Proresolving Mediators, and Resolution of Pain

A New Dual Function Dorsal Root Ganglion Stimulation in Pain Management: a Technical Note and Case Report

Modulating Neural Circuits of Pain in Preclinical Models: Recent Insights for Future Therapeutics

Neural and molecular investigation into the paraventricular thalamic-nucleus accumbens circuit for pain sensation and non-opioid analgesia

A prototype closed-loop brain–machine interface for the study and treatment of pain

Monoaminergic and Opioidergic Modulation of Brainstem Circuits: New Insights Into the Clinical Challenges of Pain Treatment?

Closed-loop stimulation using a multiregion brain-machine interface has analgesic effects in rodents

Amygdala-Targeted Relief of Neuropathic Pain: Efficacy of Repetitive Transcranial Magnetic Stimulation in NLRP3 Pathway Suppression

Non-invasive cortical stimulation for drug-resistant pain

Targeting Prefrontal Cortex Dysfunction in Pain